Search clinical trials for: everolimus eluting stents

Total 2638 results

Rudolf Berger

Unknown

Performance of Bioabsorbable Vascular Scaffolds (Absorb) Compared to Xience Stents - an Optical Coherence Tomography Study

Bioresorbable Scaffolds

Austria
Silesian Centre for Heart Diseases
Ministry of Science and Higher Education, Poland

Completed

Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease (POL-MIDES)

Coronary Artery Disease | Coronary Disease | Heart Disease | Myocardial Ischaemia

Poland
North Texas Veterans Healthcare System

Completed

AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO Study (ACE-CTO)

Coronary Occlusions

United States
University of Patras

Completed

Infrapopliteal Drug Eluting Angioplasty Versus Stenting (IDEAS-I)

Arterial Occlusive Disease

Greece
French Cardiology Society
Abbott Medical Devices

Terminated

The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontinuation of Clopidogrel (ITALIC)

Restenosis

France
Kobe University
Marquette University

Unknown

Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)

Coronary Heart Disease

Japan
Kobe University

Unknown

Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography (HEAL)

Coronary Heart Disease

Japan
Aarhus University Hospital Skejby
Odense University Hospital; University of Copenhagen; University of Aarhus

Completed

Comparison of Cypher Select and Taxus Express Coronary Stents (SORT-OUTII)

Coronary Artery Disease | Angina Pectoris
Fundacja Ośrodek Badań Medycznych

Completed

Complete Infarct Related Artery Revascularization in Acute Myocardial Infarction (CORAMIreg)

Myocardial Infarction

Poland, Slovenia
Capital Medical University
Beijing Anzhen Hospital

Completed

Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion

Coronary Artery Disease

China
Medtronic Vascular
Medtronic Bakken Research Center

Completed

RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population (R-Int)

Cardiovascular Diseases | Coronary Artery Disease

Germany
San Giuseppe Moscati Hospital

Completed

Everolimus Stent in Myocardial Infarction (RaCES-MI)

Acute Myocardial Infarction

Italy
University of Roma La Sapienza

Unknown

Effects of DES Platforms on Markers of Endothelial Damage and Inflammation (PLATFORM)

Coronary Artery Disease

Italy
Yonsei University

Completed

A New Strategy Regarding Discontinuation of Dual Antiplatelet

Coronary Artery Disease

Korea, Republic of
Cordis Corporation
Conor Medsystems

Completed

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Coronary Disease

United Kingdom
Cardiovascular Research Foundation, New York
Dickson Advanced Analytics Group

Completed

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents (ADAPT-DES)

Coronary Artery Disease

United States
Universita di Verona
Regione Piemonte

Completed

Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis

Coronary Artery Disease | Atherosclerosis | Ischemic Heart Disease

Italy
European Hospital

Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease (RENAL-DES)

Chronic Kidney Disease | Multivessel Coronary Artery Disease

Italy
Paul S Teirstein, MD
Cordis Corporation

Completed

The SCRIPPS DES REAL WORLD Registry

Coronary Artery Disease | Coronary Thrombosis | Coronary Restenosis

United States
Abbott Medical Devices

Completed

EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease (EXecutive)

Coronary Artery Disease | Coronary Disease | Coronary Artery Stenosis | Coronary Artery Restenosis

Italy
Abbott Medical Devices

Completed

EXCEL Clinical Trial (Universal Registry) (EXCEL)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Left Main Coronary Artery Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis

United States
Cardiovascular Research Center, Brazil

Completed

Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry (BRAVO)

Arterial Coronary Disease

Brazil
Cordis Corporation
Conor Medsystems

Terminated

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions (NEVO RES-I)

Coronary Atherosclerosis

Brazil, New Zealand
Cordis Corporation
Conor Medsystems

Terminated

Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions (NEVO RES-II)

Coronary Disease

Germany, Latvia
Marco Valgimigli

Unknown

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study (ZEUS)

Coronary Artery Disease

Italy, Switzerland, Portugal, Hungary
Marco Valgimigli

Completed

Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention (PRODIGY)

Coronary Artery Disease

Italy
The Hospital District of Satakunta

Completed

Titanium Nitride Oxide Coated Stents and Paclitaxel Eluting Stents for Acute Myocardial Infarction (TITAX AMI)

Acute Myocardial Infarction

Finland
Boston Scientific Corporation

Completed

A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™) (PLATINUM QCA)

Coronary Artery Disease | Atherosclerosis

Australia, New Zealand, Malaysia, Singapore
Sahajanand Medical Technologies Pvt. Ltd.

Terminated

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Coronary Artery Disease

India
Sahajanand Medical Technologies Pvt. Ltd.
Cardiovascular Research Center, Brazil

Completed

The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

Coronary Artery Disease

Brazil
The PCI Guideline Research Society

Unknown

Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion Subsets (SPECIALIST)

Coronary Artery Disease

Japan
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Association of Clopidogrel Therapy and Stent Thrombosis (REAL-LATE)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
Novartis

Completed

Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent (VAL-SUPPRES)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (DES-ISR)

In-stent Restenosis

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III) (LONG-DES-III)

Coronary Artery Disease

Korea, Republic of
Abbott Medical Devices

Completed

XIENCE V: SPIRIT WOMEN Sub-study

Myocardial Ischemia | Coronary Artery Disease | Coronary Arteriosclerosis | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Total Coronary Occlusion | Coronary Artery Restenosis

Italy, Norway, Switzerland, Denmark, Spain, Poland, Belgium, Argentina, Austria, Brazil, France, Germany, Hungary, Latvia, Netherlands
Sahajanand Medical Technologies Pvt. Ltd.

Completed

Supralimus-Core™ Pharmacokinetic (PK) Study

Coronary Artery Disease

India
Raul Moreno

Completed

Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent (CIBELES)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Terminated

Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) (TRIGGER-PCI)

Coronary Artery Disease (CAD)

United States, Germany
Seoul National University Hospital
Abbott

Unknown

Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

Coronary Artery Disease

Korea, Republic of
Medfavour (Beijing) Medical Co., Ltd
Chinese Academy of Medical Sciences, Fuwai Hospital; Division of Biometrics...

Unknown

NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System

Coronary Artery Diseases

China
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents (ISAR-TEST6)

Coronary Heart Disease

Germany
Deutsches Herzzentrum Muenchen

Unknown

Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography (PPS/PFS-OCT)

Coronary Heart Disease

Germany
North Texas Veterans Healthcare System
US Department of Veterans Affairs; University of Arkansas; Michael E. DeBakey... and other collaborators

Completed

The SOS (Stenting Of Saphenous Vein Grafts) Trial

Arteriosclerosis | Coronary Artery Bypass

United States, Greece
Yonsei University

Unknown

Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Element™ Stent Implantation (ANCHOR)

Coronary Artery Disease

Korea, Republic of
Medtronic Vascular

Completed

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System (ENDEAVOR PK)

Coronary Artery Disease

United States
Abbott Medical Devices

Completed

Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR (List of Reimbursable Products and Services) Indications in Patients Monitored for 2 Years in France (Far XIENCE V®)

Coronary Artery Disease

France
Yonsei University

Unknown

Impact of Intravascular Ultrasound(IVUS)-Guided Chronic Total Occlusion Intervention With Drug-eluting Stents (CTO)

Coronary Artery Disease

Korea, Republic of
Yonsei University

Unknown

Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation (statin)

Drug-eluting Stent (DES)

Korea, Republic of
European Cardiovascular Research Center

Unknown

Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization (PLATINUM+)

Ischemic Heart Disease | Coronary Artery Stenosis

Spain, Germany, France, United Kingdom, Italy, Netherlands, Macedonia, The Former Yugoslav Republic of, Switzerland

Search clinical trials for: everolimus eluting stents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations